» Articles » PMID: 32454462

MiR-1908/EXO1 and MiR-203a/FOS, Regulated by Scd1, Are Associated with Fracture Risk and Bone Health in Postmenopausal Diabetic Women

Overview
Specialty Geriatrics
Date 2020 May 27
PMID 32454462
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Stearoyl-coenzyme A desaturase-1 (SCD1) can inhibit the development of diabetic bone disease by promoting osteogenesis. In this study, we examined whether this regulation by SCD1 is achieved by regulating the expression of related miRNAs.

Methods: SCD1 expression levels were observed in human bone-marrow mesenchymal stem cells (BM-MSCs) of patients with type 2 diabetes mellitus (T2DM), and the effect of SCD1 on osteogenesis was observed in human adipose-derived MSCs transfected with the SCD1 lentiviral system. We designed a bioinformatics prediction model to select important differentially expressed miRNAs, and established protein-protein interaction and miRNA-mRNA networks. miRNAs and mRNAs were extracted and their differential expression was detected. The SCD1-miRNA-mRNA network was validated.

Findings: SCD1 expression in bone marrow was downregulated in patients with T2DM and low-energy fracture, and SCD1 expression promotes BM-MSC osteogenic differentiation. The predictors in the nomogram were seven microRNAs, including hsa-miR-1908 and hsa-miR-203a. SCD1 inhibited the expression of CDKN1A and FOS, but promoted the expression of EXO1 and PLS1. miR-1908 was a regulator of EXO1 expression, and miR-203a was a regulator of FOS expression.

Interpretation: The regulation of BM-MSCs by SCD1 is a necessary condition for osteogenesis through the miR-203a/FOS and miR-1908/EXO1 regulatory pathways.

Citing Articles

Identification of biomarkers and mechanism exploration of ferroptosis related genes regulated by m6A in type 2 diabetes mellitus.

Wang J, Li X, Geng J, Wang R, Ma G, Liu P Hereditas. 2025; 162(1):24.

PMID: 39966875 PMC: 11834627. DOI: 10.1186/s41065-025-00385-9.


Role of microRNA in Diabetic Osteoporosis.

Yuan Q, Wang Y, Hu S, Cai Z, Jiang L, Huang Y Mol Biotechnol. 2024; .

PMID: 39609335 DOI: 10.1007/s12033-024-01316-1.


SCD2 Regulation Targeted by miR-200c-3p on Lipogenesis Alleviates Mesenchymal Stromal Cell Senescence.

Yu X, Zhang C, Ma Q, Gao X, Sun H, Sun Y Int J Mol Sci. 2024; 25(15).

PMID: 39126105 PMC: 11313047. DOI: 10.3390/ijms25158538.


Type 2 Diabetes and Fracture Risk in Older Women.

Zoulakis M, Johansson L, Litsne H, Axelsson K, Lorentzon M JAMA Netw Open. 2024; 7(8):e2425106.

PMID: 39106069 PMC: 11304123. DOI: 10.1001/jamanetworkopen.2024.25106.


Retrospective study: risk assessment model for osteoporosis-a detailed exploration involving 4,552 Shanghai dwellers.

Han D, Fan Z, Chen Y, Xue Z, Yang Z, Liu D PeerJ. 2023; 11:e16017.

PMID: 37701834 PMC: 10494836. DOI: 10.7717/peerj.16017.


References
1.
Su Z, Yang Z, Xu Y, Chen Y, Yu Q . MicroRNAs in apoptosis, autophagy and necroptosis. Oncotarget. 2015; 6(11):8474-90. PMC: 4496162. DOI: 10.18632/oncotarget.3523. View

2.
Liu T, Fu N, Song H, Wang Y, Wu B, Shen Z . Suppression of MicroRNA-203 improves survival of rat bone marrow mesenchymal stem cells through enhancing PI3K-induced cellular activation. IUBMB Life. 2014; 66(3):220-227. DOI: 10.1002/iub.1259. View

3.
Jochum W, David J, Elliott C, Wutz A, Plenk Jr H, Matsuo K . Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat Med. 2000; 6(9):980-4. DOI: 10.1038/79676. View

4.
Minville-Walz M, Pierre A, Pichon L, Bellenger S, Fevre C, Bellenger J . Inhibition of stearoyl-CoA desaturase 1 expression induces CHOP-dependent cell death in human cancer cells. PLoS One. 2010; 5(12):e14363. PMC: 3002938. DOI: 10.1371/journal.pone.0014363. View

5.
Riserus U, Tan G, Fielding B, Neville M, Currie J, Savage D . Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma. Diabetes. 2005; 54(5):1379-84. DOI: 10.2337/diabetes.54.5.1379. View